GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: VX993
VX-993 is an approved drug
Compound class:
Synthetic organic
Comment: VX-993 is an orally bioavailable NaV1.8 ion channel inhibitor [1]. NaV1.8 is a validated target for the development of non-opioid analgesics.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. |
IUPAC Name ![]() |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-N-[6-[(1R)-1,2-dihydroxyethyl]pyridin-3-yl]-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-carboxamide |
Synonyms ![]() |
| VX993 |
Database Links ![]() |
|
| CAS Registry No. | 2877755-11-6 (source: PubChem) |
| GtoPdb PubChem SID | 507750317 |
| PubChem CID | 166158894 |
| Search Google for chemical match using the InChIKey | HXXNLIYFNQKZHX-PEHJGKTGSA-N |
| Search Google for chemicals with the same backbone | HXXNLIYFNQKZHX |
| UniChem Compound Search for chemical match using the InChIKey | HXXNLIYFNQKZHX-PEHJGKTGSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | HXXNLIYFNQKZHX-PEHJGKTGSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖